Bial

Bial is a family-owned company with a rich history of over 100 years, dedicated to patient welfare, with products available in more than 50 countries. Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), Bial has established an ambitious R&D programme. The key focus areas for the Group are neurosciences and rare diseases. The company headquarters are located in Portugal. Bial has also facilities in Spain, Germany, United Kingdom, Italy, Switzerland, US, Angola and Ivory Coast. Bial Group is a member of the “European Federation of Pharmaceutical Industries and Associations” (EFPIA). Bial has also been distinguished by its support to several medical and scientific activities, namely through Bial Foundation, having as outstanding events the Bial Award in Biomedicine, the Prémio Bial de Medicina Clínica and Scientific Research Grants, well recognised worldwide. For more information, please visit: www.bial.com For issues of safety or others related to product quality, please contact: pharmacovigilance@bial.com